Home > PS Ratio > BETA DRUGS

BETA DRUGS
PS (Price/Sales) Ratio

The Current P/S Ratio of BETA DRUGS is 6.31.

Share Price ₹2,314.7Jul 22,2026
Market Cap ₹2,569.3 Cr
Sales-TTM₹407.0 CrTTM-Consolidated Results
Price/Sales6.31xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for BETA DRUGS
Please provide your vote to see the results
BETA DRUGS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of BETA DRUGS

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of BETA DRUGS is calculated as :

Current Market Cap [ ₹2,569.3 Cr] as on Jul 22,2026

(/) Sales [ ₹407.0 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 6.31x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for BETA DRUGS , the investors are currently willing to pay '6.31 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of BETA DRUGS !

The chart below summarizes the trend in P/S Ratio of BETA DRUGS over the last five years.

Historical PS (Price/Sales) ratio chart of BETA DRUGS


PS Ratio Performance Analysis for BETA DRUGS

- BETA DRUGS 's latest p/e ratio is 6.31x.

- BETA DRUGS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 3.18x.

- BETA DRUGS 's operated at median p/e ratio of 2.96x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, BETA DRUGS 's p/e ratio peaked in Mar2025 at 5.31x.

- BETA DRUGS 's p/e ratio hit its five-year low in Mar2021 of 0.99x.


How does BETA DRUGS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
BETA DRUGS 407.06.312,569.3
SUN PHARMACEUTICAL INDUSTRIES LTD58,462.07.97466,179.0
DIVIS LABORATORIES LTD10,560.018.57196,095.0
TORRENT PHARMACEUTICALS LTD13,980.013.70191,530.0
CIPLA LTD28,162.64.06114,318.0
DR REDDYS LABORATORIES LTD33,227.92.9798,742.1
MANKIND PHARMA LTD14,277.67.36105,068.0
LUPIN LTD27,958.03.93110,002.0
ZYDUS LIFESCIENCES LTD27,148.44.15112,693.0
AUROBINDO PHARMA LTD33,653.12.6288,202.5
LAURUS LABS LTD6,812.912.5185,232.5

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs BETA DRUGS 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.62x
Max industry PS 18.57x
Median industry PS 6.31x
Average industry PS 7.65x



You may also like the below Video Courses